All News

A coordinated effort needs to be made to preserve the health and safety of life on earth.

Cancer treatments are expected to dominate much of the first wave of biosimilars in the U.S. This Q&A discussion looks at some of the questions pharmacists have about use of biosimilars in cancer treatment.

Generic drug price hikes are not likely to disappear anytime soon. Find out why they're occurring and what can be done about them.

What do pharmacists and teachers - and an awful lot of other people - have in common?

Biosimilars are the future of pharmacy. When they hit community pharmacy, issues that have been important in specialty settings are going to explode.

McKesson recognized some outstanding community pharmacies at this year's IdeaShare.

Pharmacists on P&T committees are going to face issues that range from biosimilar naming systems to challenges in dispensing and costs.

Anticoagulation briefs.

Brivaracetam provides another adjunctive treatment option for partial onset seizures in patients with uncontrolled epilepsy.

FDA has stated that it intends to continue inspections of compounding pharmacies, and it has taken aggressive action, including enforcement actions, as appropriate to protect the public health.

Once physicians see what you can do for them, they won't want to let you go.

In 2004, Rhode Island became the first state to authorize its pharmacy board to license Canadian pharmacies to ship medications to its residents.

“Basically, everything we know will be gutted over the next three years.”

Continuous medication management pays off.

And Medicare, Medicaid, and private insurers are increasingly willing to pay.

Local HIE, regional EHR, interoperability all over the place -- get your pharmacy ready. They're practically here.

The summer months can be a time of increased activity for many people, as warmer temperatures usher in numerous outdoor events that can be more strenuous and bring us closer to nature.

Glycopyrrolate bromide is a quick-onset long-acting muscarinic antagonist bronchodilator with FDA approval for use as maintenance treatment of COPD. Seebri Neohaler is approved for use at a dose of 15.6 ug inhaled twice daily.

There is a growing group of LAMA/LABA combination therapies in development. Investigations into the risks and benefits of LAMA/LABA therapy have demonstrated benefits.

Five pharmacies from four states have filed a class-action lawsuit against pharmacy benefit manager Express Scripts.

How do independent pharmacies survive? The best way to find out is to ask them.

A group of California pharmacists has sued CVS Health, accusing the retail giant of unfair business practices.

In one of the largest opioid diversion schemes to be uncovered in New York, a former pharmacy owner and her husband have pled guilty to several charges related to a multimillion-dollar oxycodone distribution scheme.

A new analysis found that Americans are misusing drugs–both illicit and prescribed drugs– at an alarming rate.

Medication reconciliation programs for patients discharged from hospitals reduced the risk of hospital readmission by 50% and helped avoid unnecessary health care costs, according to a new study.

Earlier this month, the city of Cambridge, Mass. honored retired pharmacist Emory J. “Doc” Clark by renaming a street corner after him.

So far, not many pharmacists are taking advantage of the opportunity.

Earlier this month, the U.S. Department of Justice announced that Rodney Dalton Logan, 63, of Muscle Shoals, Ala. agreed to plead guilty to obstructing a Medicare audit in 2012.